top of page
WKD VAE
bg.png

NUMBER OF HCPS
JOINED THIS MOVEMENT

00735

Healthier-Kidneys.webp

DELAY DIALYSIS, REDUCE DEATH

CKD patient education video for download and use

Enroll in the movement and be empowered with
CKD resources relevant to your practice

GP's can make the greatest impact to CKD patients by starting treatment as early as possible

SGLT2i with RAASi Up-titration Recommended for CKD Management

MOVEMENT STATEMENT

​BMI, body mass index; CKD, chronic kidney disease; GFR, glomerular filtration rate; MRA, mineralocorticoid receptor antagonist; RAASI, renin angiotensin aldosterone system RAASi, renin angiotensin aldosterone system inhibitor; SGLT2i, sodium glucose co-transport 2 inhibitor; UACR, urine albumin to creatinine ratio

^Expert Opinion

References 

  1. ACE Clinical Guideline. Chronic Kidney Disease Early Detection. October 2022

  2. Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.

  3. Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2022 Clinical Practice Guideline for diabetes management in chronic kidney disease

  4. Vart P, et al. Clin J Am Soc Nephrol. 2022 Dec;17(12):1754-1762.

  5. Heerspink H.J.L . N Engl J Med 2020; 383:1436-1446

  6. Herrington WG et al. N Engl J Med 2023; 388:117-127

  7. Perkovic V, et al. N Engl J Med 2019; 380:2295-2306

GP VAE
Anchor 3

Under the auspices of:

AstraZeneca Singapore Pte Ltd
10 Kallang Avenue, #12-10 Aperia Tower 2, Singapore 339510.
Tel: +65 681247000     Fax: +65 6385 3050

For Healthcare Professionals Only

Disclaimer:
The information presented in this material is for disease education purposes only and is not intended to substitute for the medical judgement of the healthcare provider. Statements of fact and opinions expressed in this material are not the opinion or position of AstraZeneca. AstraZeneca does not endorse or approve, and assumes no responsibility for, the content, accuracy or completeness of the information presented. Recommendations for use of any therapeutic agents or methods are based upon the best available Scientific evidence and clinical guidelines. Reference in this material to any specific commercial products, process, service, manufacturer, or company does not constitute its endorsement or recommendation.

SG-6383_CKD_20230508
SG-7622 CVRM 20240306

bottom of page